Related Experiment Videos

Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia

S G Rane1, P Dubus, R V Mettus

  • 1Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.

Nature Genetics
|May 13, 1999
PubMed

Insights

Cyclin-dependent kinase 4 (Cdk4) is crucial for mouse development and fertility. Its absence causes reduced pancreatic beta cells and diabetes, while a mutation leads to pancreatic hyperplasia.

Area of Science:

  • Cell biology
  • Molecular biology
  • Genetics

Background:

  • Cyclin-dependent kinase 4 (Cdk4) is a key regulator of the cell cycle.
  • Its precise in vivo function and role in specific cell types remain incompletely understood.

Purpose of the Study:

  • To elucidate the in vivo function of Cdk4.
  • To investigate the consequences of Cdk4 deficiency and aberrant activation.

Main Methods:

  • Targeted homologous recombination in mice to generate Cdk4-deficient and mutant Cdk4 strains.
  • Analysis of embryonic fibroblasts and whole animal phenotypes, including cell cycle progression, size, fertility, and pancreatic islet cell mass.

Main Results:

  • Mice lacking Cdk4 are viable but exhibit reduced size, infertility, and insulin-deficient diabetes due to fewer pancreatic beta-islet cells.
  • Embryonic fibroblasts lacking Cdk4 show normal proliferation but delayed S phase re-entry.
  • Mice expressing a mutant Cdk4 resistant to P16INK4a inhibition display pancreatic hyperplasia from beta-islet cell overproliferation.

Conclusions:

  • Cdk4 is essential for normal development, fertility, and the regulation of pancreatic beta-islet cell mass.
  • Cdk4 plays a critical role in controlling cell proliferation and differentiation in specific tissues.

Related Concept Videos